Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 27

1.

First Locally Acquired Congenital Zika Syndrome Case in the United States: Neonatal Clinical Manifestations.

Ventura CV, Bandstra ES, Fernandez MP, Cooper JM, Saigal GM, Bauer CR, Hofheimer JA, Berkovits MD, Fifer RC, Pensirikul AD, Gonzalez IA, Curry CL, Andreansky S, Younis RT, Liu XZ, Banker TP, Dubovy SR, Langer SM, Berrocal AM; Consortium Investigators.

Ophthalmic Surg Lasers Imaging Retina. 2018 Sep 1;49(9):e93-e98. doi: 10.3928/23258160-20180907-14.

PMID:
30222826
2.

ERBB2 Overexpression Establishes ERBB3-Dependent Hypersensitivity of Breast Cancer Cells to Withaferin A.

Liu W, Barnette AR, Andreansky S, Landgraf R.

Mol Cancer Ther. 2016 Nov;15(11):2750-2757. Epub 2016 Jul 29.

3.

Chronic spinal cord injury attenuates influenza virus-specific antiviral immunity.

Bracchi-Ricard V, Zha J, Smith A, Lopez-Rodriguez DM, Bethea JR, Andreansky S.

J Neuroinflammation. 2016 May 31;13(1):125. doi: 10.1186/s12974-016-0574-y.

4.

Chronic thoracic spinal cord injury impairs CD8+ T-cell function by up-regulating programmed cell death-1 expression.

Zha J, Smith A, Andreansky S, Bracchi-Ricard V, Bethea JR.

J Neuroinflammation. 2014 Apr 1;11:65. doi: 10.1186/1742-2094-11-65.

5.

Activation of the unfolded protein response by 2-deoxy-D-glucose inhibits Kaposi's sarcoma-associated herpesvirus replication and gene expression.

Leung HJ, Duran EM, Kurtoglu M, Andreansky S, Lampidis TJ, Mesri EA.

Antimicrob Agents Chemother. 2012 Nov;56(11):5794-803. doi: 10.1128/AAC.01126-12. Epub 2012 Aug 27.

6.

Durable immune response to inactivated H1N1 vaccine is less likely in children with sickle cell anemia receiving chronic transfusions.

Purohit S, Alvarez O, O'Brien R, Andreansky S.

Pediatr Blood Cancer. 2012 Dec 15;59(7):1280-3. doi: 10.1002/pbc.24206. Epub 2012 May 24.

PMID:
22628221
7.

A chaperone protein-enriched tumor cell lysate vaccine generates protective humoral immunity in a mouse breast cancer model.

Li G, Andreansky S, Helguera G, Sepassi M, Janikashvili N, Cantrell J, Lacasse CL, Larmonier N, Penichet ML, Katsanis E.

Mol Cancer Ther. 2008 Mar;7(3):721-9. doi: 10.1158/1535-7163.MCT-07-2067.

8.

Chaperone-rich tumor cell lysate-mediated activation of antigen-presenting cells resists regulatory T cell suppression.

Larmonier N, Cantrell J, Lacasse C, Li G, Janikashvili N, Situ E, Sepassi M, Andreansky S, Katsanis E.

J Leukoc Biol. 2008 Apr;83(4):1049-59. doi: 10.1189/jlb.0907635. Epub 2008 Jan 3.

PMID:
18174364
9.

Human ovarian tumour-derived chaperone-rich cell lysate (CRCL) elicits T cell responses in vitro.

Li G, Zeng Y, Chen X, Larmonier N, Sepassi M, Graner MW, Andreansky S, Brewer MA, Katsanis E.

Clin Exp Immunol. 2007 Apr;148(1):136-45.

10.

Natural killer cells play a key role in the antitumor immunity generated by chaperone-rich cell lysate vaccination.

Zeng Y, Chen X, Larmonier N, Larmonier C, Li G, Sepassi M, Marron M, Andreansky S, Katsanis E.

Int J Cancer. 2006 Dec 1;119(11):2624-31.

11.

Tumor-derived CD4(+)CD25(+) regulatory T cell suppression of dendritic cell function involves TGF-beta and IL-10.

Larmonier N, Marron M, Zeng Y, Cantrell J, Romanoski A, Sepassi M, Thompson S, Chen X, Andreansky S, Katsanis E.

Cancer Immunol Immunother. 2007 Jan;56(1):48-59. Epub 2006 Apr 13.

PMID:
16612596
12.

Effector CD8+ T cells recovered from an influenza pneumonia differentiate to a state of focused gene expression.

Marshall DR, Olivas E, Andreansky S, La Gruta NL, Neale GA, Gutierrez A, Wichlan DG, Wingo S, Cheng C, Doherty PC, Turner SJ.

Proc Natl Acad Sci U S A. 2005 Apr 26;102(17):6074-9. Epub 2005 Apr 14.

13.

Pathogenesis of Hong Kong H5N1 influenza virus NS gene reassortants in mice: the role of cytokines and B- and T-cell responses.

Lipatov AS, Andreansky S, Webby RJ, Hulse DJ, Rehg JE, Krauss S, Perez DR, Doherty PC, Webster RG, Sangster MY.

J Gen Virol. 2005 Apr;86(Pt 4):1121-30.

PMID:
15784906
14.

WASP- mice exhibit defective immune responses to influenza A virus, Streptococcus pneumoniae, and Mycobacterium bovis BCG.

Andreansky S, Liu H, Turner S, McCullers JA, Lang R, Rutschman R, Doherty PC, Murray PJ, Nienhuis AW, Strom TS.

Exp Hematol. 2005 Apr;33(4):443-51.

PMID:
15781335
15.

Consequences of immunodominant epitope deletion for minor influenza virus-specific CD8+-T-cell responses.

Andreansky SS, Stambas J, Thomas PG, Xie W, Webby RJ, Doherty PC.

J Virol. 2005 Apr;79(7):4329-39.

16.

The limits of protection by "memory" T cells in Ig-/- mice persistently infected with a gamma-herpesvirus.

Andreansky S, Liu H, Adler H, Koszinowski UH, Efstathiou S, Doherty PC.

Proc Natl Acad Sci U S A. 2004 Feb 17;101(7):2017-22. Epub 2004 Feb 5.

17.
18.

Defects in T-cell-mediated immunity to influenza virus in murine Wiskott-Aldrich syndrome are corrected by oncoretroviral vector-mediated gene transfer into repopulating hematopoietic cells.

Strom TS, Turner SJ, Andreansky S, Liu H, Doherty PC, Srivastava DK, Cunningham JM, Nienhuis AW.

Blood. 2003 Nov 1;102(9):3108-16. Epub 2003 Jul 10.

PMID:
12855574
19.

Quantitative analysis of long-term virus-specific CD8+-T-cell memory in mice challenged with unrelated pathogens.

Liu H, Andreansky S, Diaz G, Turner SJ, Wodarz D, Doherty PC.

J Virol. 2003 Jul;77(14):7756-63.

20.

Protection and compensation in the influenza virus-specific CD8+ T cell response.

Webby RJ, Andreansky S, Stambas J, Rehg JE, Webster RG, Doherty PC, Turner SJ.

Proc Natl Acad Sci U S A. 2003 Jun 10;100(12):7235-40. Epub 2003 May 29.

21.

Absence of a functional defect in CD8+ T cells during primary murine gammaherpesvirus-68 infection of I-A(b-/-) mice.

Belz GT, Liu H, Andreansky S, Doherty PC, Stevenson PG.

J Gen Virol. 2003 Feb;84(Pt 2):337-41.

PMID:
12560565
22.
23.

Measuring the diaspora for virus-specific CD8+ T cells.

Marshall DR, Turner SJ, Belz GT, Wingo S, Andreansky S, Sangster MY, Riberdy JM, Liu T, Tan M, Doherty PC.

Proc Natl Acad Sci U S A. 2001 May 22;98(11):6313-8. Epub 2001 May 8.

24.

Treatment of intracranial gliomas in immunocompetent mice using herpes simplex viruses that express murine interleukins.

Andreansky S, He B, van Cott J, McGhee J, Markert JM, Gillespie GY, Roizman B, Whitley RJ.

Gene Ther. 1998 Jan;5(1):121-30.

25.

Evaluation of genetically engineered herpes simplex viruses as oncolytic agents for human malignant brain tumors.

Andreansky S, Soroceanu L, Flotte ER, Chou J, Markert JM, Gillespie GY, Roizman B, Whitley RJ.

Cancer Res. 1997 Apr 15;57(8):1502-9.

26.

The application of genetically engineered herpes simplex viruses to the treatment of experimental brain tumors.

Andreansky SS, He B, Gillespie GY, Soroceanu L, Markert J, Chou J, Roizman B, Whitley RJ.

Proc Natl Acad Sci U S A. 1996 Oct 15;93(21):11313-8. Review.

27.

Comparison of genetically engineered herpes simplex viruses for the treatment of brain tumors in a scid mouse model of human malignant glioma.

Chambers R, Gillespie GY, Soroceanu L, Andreansky S, Chatterjee S, Chou J, Roizman B, Whitley RJ.

Proc Natl Acad Sci U S A. 1995 Feb 28;92(5):1411-5.

Supplemental Content

Loading ...
Support Center